Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Total revenue	$ 70,514	$ 48,706	$ 132,936	$ 91,845
Cost of services	27,562	29,949	52,573	57,852
Gross profit	42,952	18,757	80,363	33,993
Research and development	10,902	17,138	22,469	31,730
Selling and marketing	16,585	15,182	32,670	28,634
General and administrative	25,170	37,341	47,615	81,030
Impairment loss	0	0	0	2,120
Other operating expenses, net	874	718	1,848	2,465
Loss from operations	(10,579)	(51,622)	(24,239)	(111,986)
Non-operating income (expenses), net
Change in fair value of warrants and earn-out contingent liabilities	(4,409)	3,547	(10,510)	94
Interest expense, net	(894)	1,074	(1,491)	1,039
Other expense, net	(13,481)	86	(13,444)	2,802
Total non-operating income, net	(18,784)	4,707	(25,445)	3,935
Loss before income taxes	(29,363)	(46,915)	(49,684)	(108,051)
Income tax benefit	190	196	272	343
Net loss	(29,173)	(46,719)	(49,412)	(107,708)
Other comprehensive loss, net of tax
Unrealized gain related to available for sale securities, net	168	0	34	0
Comprehensive loss	$ (29,005)	$ (46,719)	$ (49,378)	$ (107,708)
Weighted average shares outstanding of Class A common stock, Basic (in shares)	26,617,955	25,418,358	26,340,063	22,754,948
Weighted average shares outstanding of Class A common stock, Diluted (in shares)	26,617,955	25,418,358	26,340,063	22,754,948
Basic net loss per share, Class A common stock (in dollars per share)	$ (1.10)	$ (1.84)	$ (1.88)	$ (4.73)
Diluted net loss per share, Class A common stock (in dollars per share)	$ (1.10)	$ (1.84)	$ (1.88)	$ (4.73)
Class A common stock
Other comprehensive loss, net of tax
Weighted average shares outstanding of Class A common stock, Basic (in shares)	26,617,955	25,418,358	26,340,063	22,754,948
Weighted average shares outstanding of Class A common stock, Diluted (in shares)	26,617,955	25,418,358	26,340,063	22,754,948
Basic net loss per share, Class A common stock (in dollars per share)	$ (1.10)	$ (1.84)	$ (1.88)	$ (4.73)
Diluted net loss per share, Class A common stock (in dollars per share)	$ (1.10)	$ (1.84)	$ (1.88)	$ (4.73)
Diagnostic test revenue
Total revenue	$ 69,439	$ 46,635	$ 130,543	$ 88,485
Other revenue
Total revenue	$ 1,075	$ 2,071	$ 2,393	$ 3,360